|Articles|January 1, 2002
Plant-derived cyclopamine vies as possible BCC treatment
Dallas - The efficacy of cyclopamine as a mechanism-based treatmentfor basal cell carcinoma is a research area that dermatologists should expectto hear more about in the future, said Stanley J. Miller, M.D., at the annualjoint meeting of the American Society for Dermatologic Surgery and the AmericanCollege of Mohs Micrographic Surgery and Cutaneous Oncology.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Transformative Advances This Year and Beyond
2
FDA Proposes Expansion of US Sunscreen Ingredient Standards with Bemotrizinol
3
Phase 3b Study Confirms Ligelizumab’s Consistent CSU Control
4
The SkinCARE Questionnaire: Assessing the Psychological Dimensions of Skin Health Beyond Disease
5














